United States · FDA National Drug Code directory
Motrin IB Migraine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50580-120_460cceff-0b2e-cbfe-e063-6394a90aa46f
- Product NDC
- 50580-120
- Form
- CAPSULE, LIQUID FILLED
- Composition / generic term
- Ibuprofen
- Labeler
- Kenvue Brands LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210118
- Source listing expiry
- 20261231
Source-listed ingredients
- IBUPROFEN — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (50580-120-20) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 50580-120-20
- 1 BOTTLE, PLASTIC in 1 CARTON (50580-120-80) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 50580-120-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →